Adaptive and maladaptive cardiovascular responses in human sepsis

Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins.

Frontiers in cardiovascular medicine·2024

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study.

Journal of thrombosis and thrombolysis·2014

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.

Journal of clinical pharmacology·2014

A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent.

Journal of thrombosis and haemostasis : JTH·2012

Antidote control of aptamer therapeutics: the road to a safer class of drug agents.

Current pharmaceutical biotechnology·2012

Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design.

Journal of thrombosis and thrombolysis·2011

Cleaner Air for Lower Cardiometabolic Risk: protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes.

American heart journal·2026

Cardiac Allograft Vasculopathy and Secondary Outcomes at 1-year in Heart Transplantation from Circulatory Death Donors.

American heart journal·2026

Dental Procedures and Associated Risk of Infective Endocarditis.

American heart journal·2026

Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial.

American heart journal·2026

Pregnancy Outcomes in Women with a History of Myocarditis.

American heart journal·2026

HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.

American heart journal·2026

Hepatitis Overview: Less Common Causes of Hepatitis.

FP essentials·2026

Hepatitis Overview: Viral Hepatitis.

FP essentials·2026

Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction.

European journal of heart failure·2026

Large Pericardial Effusion as a Manifestation of Overlapping Hydralazine-Induced Lupus and ANCA Vasculitis.

JACC. Case reports·2026

Hypotension Prediction Index versus High Mean Arterial Pressure Target for Preventing Intraoperative Hypotension: A Randomized Controlled Trial.

Anesthesiology·2026

Integrative Transcriptomics Links Dapagliflozin-Opposed Macrophage Programs to BHLHE40-Associated Regulation and NFKB1-Associated Signaling in HFpEF.

Omics : a journal of integrative biology·2026

Related Experiment Videos

Adaptive and maladaptive cardiovascular responses in human sepsis

Related Concept Videos

Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins.

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study.

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.

A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent.

Antidote control of aptamer therapeutics: the road to a safer class of drug agents.

Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design.

Cleaner Air for Lower Cardiometabolic Risk: protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes.

Cardiac Allograft Vasculopathy and Secondary Outcomes at 1-year in Heart Transplantation from Circulatory Death Donors.

Dental Procedures and Associated Risk of Infective Endocarditis.

Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial.

Pregnancy Outcomes in Women with a History of Myocarditis.

HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.

Hepatitis Overview: Less Common Causes of Hepatitis.

Hepatitis Overview: Viral Hepatitis.

Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction.

Large Pericardial Effusion as a Manifestation of Overlapping Hydralazine-Induced Lupus and ANCA Vasculitis.

Hypotension Prediction Index versus High Mean Arterial Pressure Target for Preventing Intraoperative Hypotension: A Randomized Controlled Trial.

Integrative Transcriptomics Links Dapagliflozin-Opposed Macrophage Programs to BHLHE40-Associated Regulation and NFKB1-Associated Signaling in HFpEF.

Related Experiment Videos

Adaptive and maladaptive cardiovascular responses in human sepsis

Related Concept Videos

Related Articles